FDA Issued Postmarket CVD Safety Warning for 1 in 4 Cancer Drugs FDA Issued Postmarket CVD Safety Warning for 1 in 4 Cancer Drugs

Many of these alerts occurred almost 5 after the drug approval, but the overall risk for a major cardiac event remains small, lead author says.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news